Back
Indian Angel Network > Funding Announcements  > Svastek Raises Rs 2 Cr In Seed Funding From IAN Group

Svastek Raises Rs 2 Cr In Seed Funding From IAN Group

SVASTEK, an innovative medtech startup addressing critical challenges in respiratory and critical care, has raised Rs 2 crore in seed funding from the IAN Angel Fund. This funding will drive the launch of SVASTEK’s flagship product, the ALLTIP technology-enabled NIV mask, and support the company’s vision to bring impactful solutions to the healthcare industry.

The funds raised will be utilised to launch the ALLTIP-enabled NIV mask across India, build a distributor network for seamless product availability, expand SVASTEK’s clinical application team to educate and train healthcare professionals and drive awareness through medical conferences and targeted outreach programs.

Arita Abrol, Founder, SVASTEK, said, “We’re incredibly excited to have closed this round —it’s a huge step forward for SVASTEK. This investment isn’t just about capital; it’s a validation of the vision we’ve been building toward: creating impactful, innovative solutions that transform MedTech globally. These funds will allow us to expand our team, push the boundaries of innovation, and establish ourselves in this rapidly evolving industry. India is at the cusp of MedTech innovation, and various new initiatives like MedTech Mitra, BIRAC grants, Make in India & ICMR research projects have recently been introduced. The potential here is immense, and we are just scratching the surface of what’s possible. I’m deeply grateful to our investors for believing in this journey, and I can’t wait to see how SVASTEK continues to shape the future of healthcare.”

Padmaja Ruparel, Co-founder, IAN Group, said “SVASTEK’s revolutionary ALLTIP-enabled NIV mask, which impacts critical respiratory issues. IAN is delighted parter with the founders to build a business which will promises to bring a critical care solution to India’s healthcare industry”

With plans to expand its product portfolio and geographical footprint, the company aims to establish itself as a global leader in respiratory care, driving innovation, affordability, and accessibility in healthcare.